-
Forest Laboratories and Blue Ash Therapeutics Enter Into Asset Purchase Agreement for Azimilide, a Novel Phase III Antiarrhythmic Agent
Tuesday, April 19, 2011 - 8:32am | 55Forest Laboratories, Inc. (NYSE: FRX) today announced that its wholly-owned subsidiary Forest Laboratories Holdings Limited and Blue Ash Therapeutics, LLC have entered into an asset purchase agreement, pursuant to which Forest has acquired worldwide rights to azimilide, a novel antiarrhythmic agent...
-
Benzinga's Top Pre-Market NASDAQ Losers (INVE, LOGI, ISPH, NWS)
Tuesday, April 19, 2011 - 8:22am | 115Identive Group Inc (NASDAQ: INVE) dipped 2.67% to $3.64 in the pre-market session. INVE's trailing-twelve-month ROE is -17.61%. Logitech International SA (NASDAQ: LOGI) fell 2.05% to $13.40 in the pre-market session. LOGI shares have dropped 20.00% over the past 52 weeks, while the S&P 500...
-
Forest Laboratories Reports Q4 EPS of $1.12 vs. $1.07; Revenues $1.14B vs. $1.11B
Tuesday, April 19, 2011 - 8:11am | 21Forest Laboratories (NYSE: FRX) Reports Q4 EPS of $1.12 vs. $1.07; Revenues $1.09B vs. $1.11B
-
Johnson & Johnson Reports Upbeat Q1 Earnings
Tuesday, April 19, 2011 - 7:51am | 64Johnson & Johnson (NYSE: JNJ) reported its Q1 EPS at $1.25. JNJ reported its Q1 EPS, excluding one-time items at $1.35, versus the consensus of $1.26. JNJ reported its Q1 revenue at $16.2 billion, versus the consensus of $15.83 billion. JNJ shares gained 3.16% to $62.37 in pre-market trading...
-
Johnson & Johnson Guides FY 2011 EPS $4.90-5.00 vs. $4.83 Estimate (JNJ)
Tuesday, April 19, 2011 - 7:48am | 18Johnson & Johnson (NYSE: JNJ) Guides FY 2011 EPS $4.90-5.00 vs. $4.83 Estimate
-
CORRECTION: Johnson & Johnson Reports Q1 EPS of $1.35 vs. $1.26
Tuesday, April 19, 2011 - 7:47am | 18CORRECTION: Johnson & Johnson (NYSE: JNJ) Reports Q1 EPS of $1.35 vs. $1.26
-
Johnson & Johnson Reports Q1 EPS of $1.25 vs. $1.26; Revenues $16.2B vs. $15.78B
Tuesday, April 19, 2011 - 7:46am | 21Johnson & Johnson (NYSE: JNJ) Reports Q1 EPS of $1.25 vs. $1.26; Revenues $16.2B vs. $15.78B
-
UPDATE: Piper Jaffray Raising Price Target On ViroPharma (VPHM)
Tuesday, April 19, 2011 - 7:38am | 126Piper Jaffray is raising its price target on shares of ViroPharma (NASDAQ: VPHM) to $23 from $20, and it has an Overweight rating on shares. In a note to investors, Piper Jaffray writes, "We are raising our U.S. sales estimates for Cinryze to $259 million from $253 million this year based on...
-
Deutsche Bank Maintains Hold on Eli Lilly (LLY)
Tuesday, April 19, 2011 - 7:36am | 182Deutsche Bank is out with its report today on Eli Lilly (NYSE: LLY), maintaining Hold. In a note to clients, Deutsche Bank writes, "We view LLY shares as fairly valued - hence our Hold rating. LLY's EPS vulnerability exceeds that of its peers, which have taken actions to improve earnings...
-
Novartis Reports Q1 EPS of $1.41
Tuesday, April 19, 2011 - 6:29am | 56Novartis AG (NYSE: NVS) reported its Q1 core EPS at $1.41, versus the consensus of $1.30. NVS reported its Q1 revenue at $14.03 billion, versus the consensus of $13.49 billion. NVS shares gained 3.04% to $55.88 in pre-market trading. Read more from Benzinga's Company news.
-
CEOWORLD Daily Business Roundup- BP, GS, GM, RIMM, YHOO, TXN, IBM, YHOO, C, INTC, WMT, AAPL…
Tuesday, April 19, 2011 - 6:16am | 1509BP plc (BP)- The Gulf Coast Claims Facility, established last August with $20 billion in seed money from BP, said it has approved 300,000 claims from businesses and individuals hurt by the spill, out of approximately 857,000 claims submitted. Poor trading results are likely to hurt Goldman Sachs...
-
US Stock Futures Mixed As Investors Await Goldman Sachs, Johnson & Johnson Earnings; Texas Instruments Shares Down In Pre-Market Trading
Tuesday, April 19, 2011 - 6:15am | 425US stock futures are mixed this morning, as investors are awaiting earnings from companies such as Goldman Sachs Group Inc (NYSE: GS) and Johnson & Johnson (NYSE: JNJ). Futures on the Dow Jones Industrial Average gained 4 points to 12,144.00 and futures on the S&P 500 stock index fell 0.70...
-
Earnings Scheduled For April 19 (HOG, STX, JNJ, GS, BTU, INTC, YHOO, JNPR, VMW, BK, STT, WYNN, CMA, RF, IBM, CSX)
Tuesday, April 19, 2011 - 1:15am | 424Harley-Davidson Inc (NYSE: HOG) is projected to report its Q1 earnings at $0.53 per share on revenue of $1.05 billion. Seagate Technology PLC (NASDAQ: STX) is projected to post its Q3 EPS at $0.27 on revenue of $2.66 billion. Johnson & Johnson (NYSE: JNJ) is estimated to post its Q1 EPS at $...
-
Downside a Worry? 04-18-2011
Monday, April 18, 2011 - 4:42pm | 854Cusick's Corner The EU and S&P strike, the market reacts pulling back on the open and trying to bounce into the Midday. This is the red flag that I saw coming but just didn't know what was going to be the catalyst, now we have some. If the downside is a worry, consider bear put spreads on a...
-
UPDATE: Hapoalim Raising Price Target On Amarin Corporation (AMRN)
Monday, April 18, 2011 - 1:10pm | 252Hapoalim Securities is raising its price target on shares of Amarin Corporation plc (NASDAQ: AMRN) to $23 from $12, after one of its drugs met Phase 3 expectations. In a note to clients, Hapoalim writes, "AMR101 met all primary and secondary endpoints in the Phase 3 ANCHOR trial, with...